Prescient Acquires Strategic North

Prescient Healthcare Group Acquires Uptake

January 9, 2026

Healthcare Services

Prescient Healthcare Group has acquired Uptake (Uptake Strategies Ltd), a global healthcare consultancy, to strengthen Prescient’s commercial practice and expand capabilities for pharmaceutical and biotech clients. The deal is supported by Prescient’s existing investor Bridgepoint Development Capital; Uptake’s CEO Stephanie Hall will join Prescient’s board and lead the combined Commercial Practice during integration.

Bridgepoint Development Capital Recapitalizes Prescient Healthcare Group

January 21, 2021

Healthcare Services

Bridgepoint Development Capital led a recapitalization of Prescient Healthcare Group, a London-based product strategy consultancy serving the global biopharmaceutical industry; the transaction closed January 19, 2021. Baird Capital (the exiting majority investor) provided a full exit but reinvested as a minority shareholder alongside Bridgepoint to support Prescient's next phase of growth and international expansion.

Sequoia Consulting Group Acquires 42 North Solutions

February 22, 2023

Healthcare Services

Sequoia Consulting Group, a Riverside Partners portfolio company, has acquired 42 North Solutions, a Scituate, MA-based provider of capital project execution, facilities engineering, and facilities management services for pharmaceutical and biotechnology clients. The add-on expands Sequoia's East Coast presence, strengthens facilities management capabilities, and adds depth to its process, automation, and project engineering offerings; financial terms were not disclosed.

JPA Health Acquires True North Solutions

October 19, 2023

Healthcare Services

JPA Health, a Great Point Partners-backed full-service healthcare agency, has acquired True North Solutions, a Cambridge, Massachusetts-based life sciences consulting firm that specializes in predictive analytics, AI-driven solutions and medical affairs. The deal (an add-on to JPA Health) brings True North's analytics, visualization and AI capabilities into JPA's life sciences offerings and transitions True North founder Colin Baughman and his team into JPA Health.

Accenture Acquires Bionest to Expand Life Sciences Strategy Capabilities

February 2, 2023

Healthcare Services

Accenture has acquired Bionest, a New York–based strategy and consulting firm focused on life sciences, bringing Bionest's 46 consultants into Accenture Strategy to bolster its Life Sciences practice. The acquisition expands Accenture's capabilities across precision medicine, diagnostics, oncology, cell & gene therapy, and rare diseases; terms were not disclosed.

Danforth Advisors Acquires PharmaDirections

August 25, 2025

Healthcare Services

Danforth Advisors, a PE-backed life sciences advisory platform, has acquired PharmaDirections, a virtual drug development partner. The acquisition adds more than 150 specialists and expands Danforth's integrated capabilities across discovery, non-clinical and clinical development, CMC, regulatory strategy, and program and alliance management.